Immune therapy stops diabetes in mouse study
|
Tweet
|
|
Using one type of immune system cell to turn off another stopped type-1 diabetes in mice, U.S. researchers said on Monday.
The study suggests it may be possible to retrain a faulty immune system, stopping it from attacking the pancreas and causing type-1 or juvenile diabetes, the researchers said.
Writing in the Journal of Experimental Medicine, Kristin Tarbell and colleagues at Rockefeller University in New York said they used immune system cells called dendritic cells to stimulate production of suppressor T-cells.
These T-cells turn off the body’s faulty immune response. In the case of the mice, they stopped the destruction of their pancreatic islet cells that causes type-1 diabetes.
Type-1 or juvenile diabetes is an autoimmune disease, caused when immune cells for unknown reasons destroy healthy tissue. In diabetes, they kill off the cells in the pancreas that make insulin.
An estimated 2 million Americans have type-1 diabetes.
“You have to stop the immune system from attacking those pancreatic islet cells,” Tarbell said in a statement
“Instead of silencing the attackers directly, we learned how to generate another type of cell, called a regulatory or suppressor cell, which essentially turns off the attackers,” Tarbell added.
What works in mice may not necessarily work in people, the researchers caution.
But the immune systems are highly similar.
Dendritic cells signal to T-cells, helping them identify which invaders to attack and which to tolerate.
For their study, the Rockefeller team removed suppressor T-cells from the mice, grew more of them in lab dishes, and injected them back into the mice. They also purified the compounds used by dendritic cells to signal the T-cells and used them to make the suppressor-T-cells proliferate.
For the method to work, diabetes will have to be diagnosed very early, Tarbell noted.
“If this method for restoring the balance of suppressor T-cells proves effective all the way through our research and into humans, we still need to intervene before the islet cells are completely destroyed,” Tarbell said.
“Measuring early onset will be just as important as treating it.”
Revision date: June 22, 2011
Last revised: by Janet A. Staessen, MD, PhD
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

